Clinical trial
An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Glycemic Control Using Hybrid-closed Loop vs. Advanced Hybrid Closed-loop in Young Subjects With Type 1 Diabetes
NCT04269668 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Glycemic Control Using Hybrid-closed Loop vs. Advanced Hybrid Closed-loop in Young Subjects With Type 1 Diabetes
- Lead sponsor
- Rabin Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 19, 2020
- Completion date
- March 20, 2021
- Enrollment
- 28 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.